03:01pm Deutsche Bank Adjusts Price Target on Nasdaq to $116 From $111, Maintains Buy Rating MT
02:58pm Kolibri Global Energy Provides Operations Update on Tishomingo Field Wells MT
02:58pm Morgan Stanley Adjusts Price Target on eBay to $112 From $102, Maintains Overweight Rating MT
02:57pm Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Tuesday; Rocket Lab to Advance, Microsoft to Decline MT
02:55pm Jefferies Adjusts Price Target on Regeneron Pharmaceuticals to $885 From $870, Maintains Buy Rating MT
02:55pm Raymond James Adjusts PT on Regeneron Pharmaceuticals to $820 From $800, Keeps Outperform Rating MT
02:37pm Baidu CFO on Business Strategy, AI Investments MT
02:14pm TD Cowen Adjusts Price Target on Meta Platforms to $820 From $810, Maintains Buy Rating MT
02:09pm Kolibri Global Energy Brief: Provided Operations Update On Its Latest Wells In Its Tishomingo Field in Oklahoma MT
02:08pm Evotec says Michael Kaufman holds 5.03% of total voting rights and instruments in Evotec RE
02:06pm Amgen's Extension Study Shows MariTide Helped Maintain Weight Loss at Lower Dose, Less Frequency MT
01:53pm Canada's OpenText Opens Regional Headquarters in Saudi Arabia MT
01:49pm KeyBanc Upgrades Intel to Overweight From Sector Weight, Price Target is $60 MT
01:49pm Piper Sandler Downgrades Synopsys to Neutral From Overweight, Adjusts PT to $520 From $602 MT
01:13pm BioMarin Pharmaceutical Reports Preliminary 2025 Revenue, Details Asset Write-Down MT
01:11pm Alnylam Pharmaceuticals CEO on Development Goals, Profitability MT
12:51pm Microsoft to Modify Data Center Power Use Following Trump Agreement MT
12:41pm Oak Valley Bancorp Names Bill Nunes as Chief Marketing Officer MT
12:31pm Apple, Google strike Gemini deal for revamped Siri RE
11:50am Forvia Hella announces strategic development with Analog Devices RE
11:35am Kratos Defense & Security Solutions Insider Sold Shares Worth $2,355,667, According to a Recent SEC Filing MT
10:35am CME changes margin-setting methodology for precious metals RE
08:50am Press digest - New York Times business news - January 13 RE
03:41am Amgen says MariTide helped trial patients maintain weight loss RE
03:11am Amgen's MariTide phase 2 study shows 'meaningful' reduction in blood sugar, weight RE
02:59am Trump says Microsoft to make changes to curb data center power costs for Americans RE
02:54am Amgen: Second year of Maritide treatment very well tolerated including at quarterly doses, with very low incidence of nausea, vomiting & no new safety signals observed RE
02:54am Amgen: "Large majority" of people in 52-week Maritide extension study given lower monthly dose or quarterly dose of drug maintained weight loss achieved in part 1 of phase 2 trial RE
02:50am Amgen says 24-week study of monthly Maritide in people with type 2 diabetes showed robust, clinically meaningful reduction in both HbA1c, weight RE
02:46am Amgen to announce data on obesity drug MariTide at healthcare conference RE
02:15am Medallion Bank - promotes Travis Betenson to SVP and CFO RE
01-13 Microsoft-Backed OpenAI Agrees to Buy Health AI Startup Torch in $100 Million Deal MT
01-13 Tech Up on AI Views -- Tech Roundup DJ
01-13 Meta to Cut 10% Jobs in Reality Labs MT
01-13 Cadence Design Systems Insider Sold Shares Worth $2,009,189, According to a Recent SEC Filing MT
01-13 MercadoLibre lays off 119 people due to its AI expansion, Folha reports RE
01-13 Matthews International to Redeem Senior Secured Notes due 2027 MT
01-13 Biomarin Pharmaceutical Inc estimates $3.2 billion in total revenues for FY - SEC filing RE
01-13 BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer MT
01-13 Acadia Pharmaceuticals Focuses on Next-Gen Neuroscience MT
No results for this search
Detailed heatmap